These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6130101

  • 1. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
    Shibasaki T, Nakahara M, Shizume K, Kiyosawa Y, Suda T, Demura H, Kuwayama A, Kageyama N, Benoit R, Ling N.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
    [Abstract] [Full Text] [Related]

  • 2. Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.
    Shibasaki T, Masui H.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):872-6. PubMed ID: 6126487
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW, Verleun T, Oosterom R, de Jong F, Hackeng WH.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH, Schulte HM, Chrousos GP, Gold PW, Benker G, Peterson RE, Cutler GB, Loriaux DL.
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [Abstract] [Full Text] [Related]

  • 5. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
    Takeda R, Ito T, Kawato M, Nakabayashi H, Miyamori I, Morise T, Koshida H, Ikeda M.
    Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
    [Abstract] [Full Text] [Related]

  • 6. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
    Oosterom R, Verleun T, Uitterlinden P, Hackeng WH, Burbach JP, Wiegant VM, Lamberts SW.
    Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
    [Abstract] [Full Text] [Related]

  • 7. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
    Suda T, Tomori N, Tozawa F, Demura H, Shizume K.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
    [Abstract] [Full Text] [Related]

  • 8. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
    Chan JS, Gaspar L, Iguchi H, Seidah NG, Ling N, Chrétien M.
    Clin Invest Med; 1984 Nov; 7(4):205-8. PubMed ID: 6335868
    [Abstract] [Full Text] [Related]

  • 9. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
    Gaspar L, Chan JS, Seidah NG, Chrétien M.
    Clin Invest Med; 1985 Nov; 8(2):167-75. PubMed ID: 3009068
    [Abstract] [Full Text] [Related]

  • 10. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T, Tozawa F, Mouri T, Sasaki A, Shibasaki T, Demura H, Shizume K.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
    [Abstract] [Full Text] [Related]

  • 11. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T, Ishibashi M, Teramoto A, Fukushima T.
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [Abstract] [Full Text] [Related]

  • 12. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S, Nakao K, Tanaka I, Horii K, Nakai Y, Shimbo S, Watanabe M, Nakane T, Kuwayama A, Kageyama N, Imura H.
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [Abstract] [Full Text] [Related]

  • 13. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
    Nakashima H, Hirata Y, Uchihashi M, Tomita M, Fujita T.
    Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS, Lu CL, Seidah NG, Chretien M.
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [Abstract] [Full Text] [Related]

  • 15. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T, Ishibashi M, Teramoto A, Fukushima T.
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [Abstract] [Full Text] [Related]

  • 16. Characterization of lipotropin-, corticotropin-, and beta-endorphin-immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome.
    Bertagna X, Luton JP, Binoux M, Bricaire H, Girard F.
    J Clin Endocrinol Metab; 1979 Oct; 49(4):527-32. PubMed ID: 225344
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M, Yamada M, Demura H.
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [Abstract] [Full Text] [Related]

  • 18. Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects.
    Westphal M, Jaquet P, Wilson CB.
    Acta Neuropathol; 1986 Dec; 71(1-2):111-8. PubMed ID: 3022531
    [Abstract] [Full Text] [Related]

  • 19. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
    Martin R, Cetin Y, Fehm HL, Fahlbusch R, Voigt KH.
    Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
    [Abstract] [Full Text] [Related]

  • 20. In vitro secretion of ACTH, beta-endorphin and beta-lipotropin in Cushing's disease and Nelson's syndrome.
    Lüdecke DK, Westphal M, Schabet M, Höllt V.
    Horm Res; 1980 Mar; 13(4-5):259-79. PubMed ID: 6268513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.